Bli medlem
Bli medlem

Du är här


Elekta: Elekta's Nomination Committee for the 2017 Annual General Meeting

STOCKHOLM, November 9, 2016 - In accordance with the resolution passed
by Elekta's (EKTA-B.ST) Annual General Meeting on September 1, 2016,
the Chairman of the Board has contacted the company's four largest
shareholders in terms of votes, in addition to the shareholder or
shareholders represented by the Chairman himself, each of whom
expressed an interest in participating in the Nomination Committee,
and appointed one member (see below) to form Elekta's Nomination
Committee together with the Chairman of the Board. The procedure is
described in detail in the notice of the 2016 Annual General Meeting.

Nomination Committee members:

· Laurent Leksell, in his capacity as Chairman of the Board of
Elekta and representing his own and related parties' holdings

· Åsa Nisell, appointed by Swedbank Robur funds
· Per Colleen, appointed by the Fourth Swedish National Pension Fund
· Magnus Henjeby, appointed by Nordea Investment funds
· Tomas Flodén, appointed by AMF Försäkring & Fonder
The Nomination Committee will appoint one of its members as Chairman.

The Nomination Committee is to present proposals for resolutions by
the 2017 Annual General Meeting of Shareholders in relation to the
following: Chairman of the Annual General Meeting of Shareholders,
Chairman of the Board of Directors and other members of the Board of
Directors, Fees to the Board of Directors broken down into amounts
for the Chairman of the Board of Directors, other members of the
Board of Directors and members of the Board of Directors' committees,
External auditor and fees to the auditor, and where deemed necessary,
proposal to amend the procedure for the Nomination Committee.

Shareholders wishing to submit proposals to Elekta's Nomination
Committee can do so by e-mail to or by
letter to:

Elekta AB, Nomination Committee
Box 7593
SE-103 93 Stockholm
# # #

For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail:
Time zone: CET: Central European Time
Gert van Santen, Group Vice President Corporate Communications, Elekta

Tel: +31 653 561 242, e-mail:
Time zone: CET: Central European Time
This is information that Elekta AB (publ) is obliged to make public
pursuant to the EU Market Abuse Regulation. The information was
submitted for publication at 07:30 CET on November 9, 2016.

About Elekta
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The
company develops sophisticated, state-of-the-art tools and treatment
planning systems for radiation therapy, radiosurgery and
brachytherapy, as well as workflow enhancing software systems across
the spectrum of cancer care. Stretching the boundaries of science and
technology, providing intelligent and resource-efficient solutions
that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,600 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on NASDAQ Stockholm. Website:


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.